International Pharma Supplies Analytical Samples for Biosimilar Development Unlicensed Medicines Supplies Comparator Sourcing for clinical trials

International Pharma Supplies

We supply prescription only and OTC products to authorized wholesalers, licensed importers and aid organisations – from anywhere in the EU with a focus on German products.

Analytical Samples for Biosimilar Development

We supply analytical samples for Biosimilar development from almost anywhere in the world – Multi-country, Multi-batch and Multi-expiry date approach.

Unlicensed Medicines Supplies

We supply prescription only and OTC products to companies that have specialized in unlicensed medicines supplies, government agencies, hospitals and pharmacies.

Comparator Sourcing for clinical trials

We source Comparator products from almost anywhere in the World and have direct access to many innovators and approved supply sources.

Comparator Sourcing
for clinical trials

Analytical Samples for Biosimilar Development

Unlicensed Medicines Supplies

Pharma Supplies

Amgen Biosimilars: First submission for Humira biosimilar in the United States

Amgen announced the submission of a Biologics License Application (BLA) with the United States FDA for ABP 501, a biosimilar candidate to Humira (adalimumab). Amgen believes this submission is the first ...

Samsung Bioepis wins EMA nod for the first etanercept biosimilar in the European Union

Samsung Bioepis Co., Ltd. announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Benepali – a biosimilar version of ...

Cinfa Biotech treats first subjects in pegfilgrastim biosimilar clinical trial

Cinfa Biotech S.L., the biosimilars company of Infarco group, today announced that the first subjects have been dosed in a clinical trial of B12019, a biosimilar version of Neulasta(R) (pegfilgrastim) to treat ...

Epirus expands biosimilar pipeline and capabilities

Epirus Biopharmaceuticals, Inc., announced an agreement for the acquisition of Bioceros Holding B.V., enabling Epirus to expand its biosimilar pipeline and vertically integrate product development ...

Intas launches Razumab, the first biosimilar to Lucentis

Intas Pharmaceuticals has launched Razumab™, its biosimilar to Lucentis® (Ranibizumab). Intas is the first company globally to develop and launch a biosimilar version of Ranibizumab. Razumab is ...

FDA approves first biosimilar Zarxio (filgrastim-sndz) from Sandoz

Sandoz, a Novartis company, announced that the US Food and Drug Administration (FDA) approved Zarxio (filgrastim-sndz) for all indications included in the reference product’s label. Sandoz is the first ...

Medizone Campaign – Comparator Sourcing – Clinical Trials Insight

Opening up new dimensions in comparator sourcing for clinical trials. Being a pioneer means having a vision. Medizone as a strategic comparator sourcing partner for clinical trials and specialist for ...

Medizone – Splendid similarities – WorldPharma | Comparator Sourcing

Recent MEDIZONE article - WorldPharma - Clinical Trials Insight "Splendid similarities The benefits of biosimilars have long been championed in the medical sector, but with their use set to increase in ...

Samsung Bioepis submits Enbrel biosimilar to EMA

Samsung Bioepis Co., Ltd., announced that the Marketing Authorization Application (MAA) for its Enbrel (etanercept) biosimilar candidate, SB4 has been validated and accepted for review by European Medicines ...

Ranbaxy launches first Biosimilar Infliximab in India!

Ranbaxy Laboratories Limited (Ranbaxy), one of India’s largest pharmaceutical company, announced on 1.12.2014 the launch of Infimab (BOW015), the first Remicade (infliximab) biosimilar in India. Infimab, ...